Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review

BACKGROUND: Iron supplementation and erythropoiesis-stimulating agent (ESA) administration represent the hallmark therapies in preoperative anemia treatment, as reflected in a set of evidence-based treatment recommendations made during the 2018 International Consensus Conference on Patient Blood Man...

Descripción completa

Detalles Bibliográficos
Autores principales: Laermans, Jorien, Van Remoortel, Hans, Avau, Bert, Bekkering, Geertruida, Georgsen, Jørgen, Manzini, Paola Maria, Meybohm, Patrick, Ozier, Yves, De Buck, Emmy, Compernolle, Veerle, Vandekerckhove, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578279/
https://www.ncbi.nlm.nih.gov/pubmed/36253838
http://dx.doi.org/10.1186/s13643-022-02081-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578279/
https://www.ncbi.nlm.nih.gov/pubmed/36253838
http://dx.doi.org/10.1186/s13643-022-02081-5

Ejemplares similares